BL Pharmtech Corp.
Financials
Valuation Metrics
BL Pharmtech Corp.'s Market Cap is ₩475B. At end of 2025 it was ₩153B. Ranked #1751 of 2,405 in KR market (top 73%), #1063 of 1,627 on KOSDAQ (top 65%), #34 of 56 in Household & Personal Products (top 61%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 47.45B KRW | KR#1,751/2,405 Sec#34/56 |
| Revenue | 3.95B KRW | KR#2,339/2,405 Sec#55/56 |
| Net Income | -15.15B KRW | KR—/2,405 Sec—/56 |
| Total Assets | 17.07B KRW | KR#2,373/2,405 Sec#55/56 |
| Net Assets | 8.35B KRW | KR#2,366/2,405 Sec#56/56 |
| Employees | 16 | KR#2,254/2,405 Sec#55/56 |
| Value | ||
| P/B | 5.68x | KR#2,277/2,405 Sec#54/56 |
| P/S | 12.02x | KR#2,287/2,405 Sec#55/56 |
| Profitability | ||
| ROE | -181.49% | KR#2,361/2,405 Sec#56/56 |
| ROA | -88.77% | KR#2,378/2,405 Sec#56/56 |
| Op. Margin | -52.70% | KR#2,224/2,405 Sec#52/56 |
| Revenue Growth | -54.27% | KR#2,284/2,405 Sec#56/56 |
| Financial Health | ||
| Debt Ratio | 104.46% | KR#1,592/2,405 Sec#42/56 |
| Total Debt | 3.08B KRW | KR#1,848/2,405 Sec#41/56 |
| Cash | 5.79B KRW | KR#1,952/2,405 Sec#43/56 |
| Current Ratio | 0.95x | KR#1,772/2,405 Sec#38/56 |
| Performance | ||
| 1Y Return | 154.11% | KR#42/2,405 Sec#1/56 |
| 1M Return | -23.42% | KR#2,034/2,405 Sec#51/56 |
| From 52W High | -79.14% | KR#2,276/2,405 Sec#54/56 |
| 1Y MDD | -76.39% | KR#2,189/2,405 Sec#53/56 |
| Trading | ||
| Volume | 154,816 shares | KR#464/2,405 Sec#7/56 |
| Trading Value | 260.8M KRW | KR#1,037/2,405 Sec#23/56 |
| Foreign Own. | 1.36% | KR#1,876/2,405 Sec#35/56 |
| Per Share | ||
| EPS | -543 KRW | KR—/2,405 Sec—/56 |
| BPS | 299 KRW | KR#2,393/2,405 Sec#56/56 |
Company Info
BL Pharmtech, established in 1995 and listed on KOSDAQ in 2002, is a specialized healthcare distribution company. It distributes health functional foods and general foods, and manufactures and sells in-vitro diagnostic medical devices, owning brands NFP, Boidang, and ramen brand Mister Min. Leveraging 30 years of distribution experience, the company has built extensive online and offline distribution networks. BL Pharmtech is diversifying its healthcare operations by entering the European ready-to-eat food market and expanding its diagnostic kit business. It is headquartered in Gyeonggi-do, Yongin-si.